Author Index

Search or browse for an author across our entire electronic archive

Search results for: D
Results 1 - 10 of 1213 shown below

  • Dávila-Loaiza, G

    I Contreras-Hernández, J F Mould-Quevedo, A Silva, G Salinas-Escudero, M A Villasís-Keever, V Granados-García, G Dávila-Loaiza, J A Petersen and J Garduño-Espinosa

    A pharmaco-economic analysis of second-line treatment with imatinib or sunitinib in patients with advanced gastrointestinal stromal tumours

    advance online publication, 2008-05-27 00:00:00.000;

    doi:10.1038/sj.bjc.6604367

  • D'Agostino, G

    G D'Agostino, G Ferrandina, M Ludovisi, A Testa, D Lorusso, N Gbaguidi, E Breda, S Mancuso and G Scambia

    Phase II study of liposomal doxorubicin and gemcitabine in the salvage treatment of ovarian cancer

    doi:10.1038/sj.bjc.6601284

  • D'Alessandro, A

    P Tassone, P Tagliaferri, C Viscomi, C Palmieri, M Caraglia, A D'Alessandro, E Galea, A Goel, A Abbruzzese, C R Boland and S Venuta

    Zoledronic acid induces antiproliferative and apoptotic effects in human pancreatic cancer cells in vitro

    doi:10.1038/sj.bjc.6600986

  • D'Alessio, G

    D Spalletti-Cernia, R Sorrentino, S Di Gaetano, R Piccoli, M Santoro, G D'Alessio, P Laccetti and G Vecchio

    Highly selective toxic and proapoptotic effects of two dimeric ribonucleases on thyroid cancer cells compared to the effects of doxorubicin

    doi:10.1038/sj.bjc.6601491

  • D'Alessio, V

    R De Santis, A M Anastasi, V D'Alessio, A Pelliccia, C Albertoni, A Rosi, B Leoni, R Lindstedt, F Petronzelli, M Dani, A Verdoliva, A Ippolito, N Campanile, V Manfredi, A Esposito, G Cassani, M Chinol, G Paganelli and P Carminati

    Novel antitenascin antibody with increased tumour localisation for Pretargeted Antibody-Guided RadioImmunoTherapy (PAGRITR)

    doi:10.1038/sj.bjc.6600818

  • D'Amico, C

    V Lorusso, E Crucitta, N Silvestris, A Catino, L Caporusso, A Mazzei, M Guida, A Latorre, D Sambiasi, C D'Amico, F Schittulli, P Calabrese and M De Lena

    Phase I/II study of gemcitabine plus mitoxantrone as salvage chemotherapy in metastatic breast cancer

    doi:10.1038/sj.bjc.6600780

  • D'Angelo, A

    S Cascinu, M Scartozzi, R Labianca, V Catalano, R R Silva, S Barni, A Zaniboni, A D'Angelo, S Salvagni, G Martignoni, G D Beretta, F Graziano, R Berardi and V Franciosi

    High curative resection rate with weekly cisplatin, 5-fluorouracil, epidoxorubicin, 6S-leucovorin, glutathione, and filgastrim in patients with locally advanced, unresectable gastric cancer: a report from the Italian Group for the Study of Digestive Tract

    advance online publication, 2004-03-30 00:00:00.000;

    doi:10.1038/sj.bjc.6601752

  • D'Aprile, M

    A Piga, R Nortilli, G L Cetto, N Cardarelli, S Luzi Fedeli, G Fiorentini, M D'Aprile, F Giorgi, A P Parziale, A Contu, R Montironi, R Gesuita, F Carle and R Cellerino

    Carboplatin, doxorubicin and etoposide in the treatment of tumours of unknown primary site

    advance online publication, 2004-04-13 00:00:00.000;

    doi:10.1038/sj.bjc.6601785

  • D'Ascenzo, S

    A Ferretti, S D'Ascenzo, A Knijn, E Iorio, V Dolo, A Pavan and F Podo

    Detection of polyol accumulation in a new ovarian carcinoma cell line, CABA I: a1H NMR study

    doi:10.1038/sj.bjc.6600189

  • D'Ath, S

    P Corrie, A Mayer, J Shaw, S D'Ath, S Blagden, C Blesing, P Price and N Warner

    Phase II study to evaluate combining gemcitabine with flutamide in advanced pancreatic cancer patients

    doi:10.1038/sj.bjc.6600523